Supply Issues Becton Dickinson UK Ltd Hypodermic Syringe FWC244 (ICN 3434)

• The supply issue with hypodermic syringe from Becton Dickinson is continuing.
• One product is no longer subject to Demand Management and is now suspended and unavailable to order:
  • FWC244 – Hypodermic Syringe – 3ml Luer Lock 3 Piece Concentric Clear Sterile.
• Potential indirect alternative products are available to order through our online catalogue for the affected product. However, some of these products may also become subject to intermittent supply with the increase in demand.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is anticipated to be resolved by 28 September 2026.

Change:

• The supplier Becton Dickinson UK Ltd has informed us of a supply issue with its hypodermic syringe.
• There is one product code affected:
  • FWC244 – Hypodermic Syringe – 3ml Luer Lock 3 Piece Concentric Clear Sterile.
• The supply issue is due to increased demand and lead times.
• Due to this ongoing supply, issue this product is now being threshold managed as it is subject to Protect Demand Management.

Impact:

• The affected product is still available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Potential indirect alternative products are available to order through our online catalogue:
  • FWC196 – Hypodermic Syringe – 2 to 3ml Luer Lock Concentric Clear Plunger Sterile
  • FWC700 – Hypodermic Syringe – 3ml Luer Slip 3 Piece Concentric clear Sterile
  • FWC701 – Hypodermic Syringe – 3ml Luer Lock 3 Piece Concentric clear Sterile.
• We are currently sourcing further alternatives and updates will be made to the product listing as soon as possible.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives and for a full list of product codes subject to Protect Demand Management.
• The supply issue is anticipated to be resolved by 7 September 2026.

Next Steps:               

• Customers are advised to log into our website to view the potential indirect alternative products and to view the product codes currently subject to Protect Demand Management.
• The continuing supply issue is being monitored in conjunction with the supplier, and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.